TrialNature medicine2025
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials.
Shen Zhao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled ittrialcites it